Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
27 studies found for:    golimumab, ulcerative colitis
Show Display Options
Rank Status Study
1 Unknown  Physiological Intermolecular Modification Spectroscopy (PIMS) in Ulcerative Colitis With Golimumab
Condition: Ulcerative Colitis
Intervention: Drug: Golimumab
2 Completed Golimumab Utilization and Impact on Ulcerative Colitis (MK-8259-032)
Condition: Ulcerative Colitis
Intervention: Drug: Golimumab
3 Recruiting Study of the Pharmacokinetics of Golimumab in Moderate to Severe Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention:
4 Active, not recruiting A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative Colitis
Condition: Colitis, Ulcerative
Intervention: Drug: Golimumab
5 Not yet recruiting Intermittent Treatment After Reaching the taRget With Golimumab for ulcErative coliTis - (TARGET)
Condition: ULCERATIVE COLITIS
Intervention: Drug: GOLIMUMAB
6 Recruiting Golimumab Effect in the Modulation of Gut Microbiota in Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: Golimumab
7 Completed
Has Results
Preference for a Prefilled Syringe or Smartject™ Device for Delivering Golimumab in Participants Suffering From Moderate-to-severe Ulcerative Colitis (MK-8259-027)
Condition: Ulcerative Colitis
Interventions: Drug: Prefilled Syringe delivery of Golimumab;   Drug: Smartject Device delivery of Golimumab
8 Unknown  Golimumab in Steroid-dependent Ulcerative Colitis: Induction and Maintenance of Clinical and Endoscopic Remission
Condition: Colitis, Ulcerative
Intervention: Drug: Golimumab
9 Not yet recruiting The Belgian SMART Study Evaluating the Use of Golimumab for Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention:
10 Completed
Has Results
A Safety and Effectiveness Study of Golimumab in Japanese Patients With Moderately to Severely Active Ulcerative Colitis.
Condition: Colitis, Ulcerative
Interventions: Drug: Golimumab;   Other: Placebo
11 Completed A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
Condition: Colitis, Ulcerative
Intervention: Biological: Golimumab
12 Terminated
Has Results
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
Condition: Colitis, Ulcerative
Interventions: Other: Placebo;   Drug: Golimumab 1 mg per kg;   Drug: Golimumab 2 mg per kg;   Drug: Golimumab 4 mg per kg
13 Completed
Has Results
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
Condition: Colitis, Ulcerative
Interventions: Biological: Placebo;   Biological: Golimumab 100 mg;   Biological: Golimumab 200 mg;   Biological: Golimumab 400 mg;   Biological: Golimumab 50 mg
14 Recruiting Efficacy of Golimumab in Maintaining Deep Remission in UC Patients in Prolonged Remission With Infliximab
Condition: Ulcerative Colitis
Intervention:
15 Active, not recruiting Correlation of Soluble ST2 With Golimumab (MK-8259) Response in Participants With Ulcerative Colitis (UC) (MK-8529-022).
Condition: Colitis, Ulcerative
Intervention: Biological: Golimumab
16 Completed
Has Results
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
Condition: Colitis, Ulcerative
Interventions: Biological: Placebo;   Biological: Golimumab 50 mg;   Biological: Golimumab 100 mg;   Biological: Golimumab 200 mg
17 Not yet recruiting Study of the Golimumab Exposure-Response Relationship Using Serum Trough Levels
Condition: Ulcerative Colitis
Intervention: Drug: Golimumab
18 Not yet recruiting Predicting Clinical Response to Golimumab With Mucosal Barrier Dysfunction
Condition: Ulcerative Colitis
Intervention: Other: patients receiving biopsies
19 Recruiting An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention:
20 Not yet recruiting Anti-tumor Necrosis Factor in Patients With Ulcerative Colitis in Clinical Remission: to Continue or Not?
Condition: Colitis,Ulcerative
Interventions: Other: Discontinuation of anti-TNF treatment;   Other: Continuation of anti-TNF treatment

   Previous Page Studies Shown (1-20) Next Page (21-27) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.